ArticleInternational wound journal2026
The Australian Diabetes Foot Registry: From Conceptualisation to National Collaboration.
Article in International wound journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The Australian Diabetes Foot Registry (ADFR) is a national prospective, longitudinal clinical quality registry established in 2020 to standardise data capture and reporting in Interdisciplinary Diabetes High Risk Foot Services. We describe the ADFR's methodology and early implementation outcomes. Stakeholder consultation informed development of the minimum dataset, governance framework and data-capture workflow. Centrally supported ethics and jurisdictional approvals facilitated site onboarding. Clinical, management and outcome data were collected, de-identified and amalgamated in a national repository. Implementation outcomes included recruitment metrics, case ascertainment, mandatory-field missing data, reporting cycles, conference presentations and inaugural report feedback. Seventy-four sites expressed interest and 49 sites completed implementation. Median time from application to commencement was 7 (IQR 4-12) months under a nationally recognised ethics approval. By mid-2025, 10 919 participants were registered, comprising 13 150 care episodes and 22 383 ulcerations. In 2024-2025, mean service-level case ascertainment was 80%, and the mandatory-field missing data rate was 0%-7%. Four annual reporting cycles have been completed, all services strongly endorsed participation after the inaugural report, and data informed 29 conference presentations. The ADFR demonstrates a feasible, scalable national registry model, enabling timely audit and benchmarking and actionable reporting to support quality improvement, research and collaboration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.